June 22, 2024

Biopsy Devices Market Size To Increase USD 4.29 Billion By 2032

The global Biopsy devices market size was estimated to be around US$ 2.29 billion in 2023 and is projected to reach US$ 4.29 billion by 2032, indicating a CAGR of 7.20% from 2023 to 2032.

Biopsy Devices Market Size 2023 To 2032

Key Takeaways

  • North America region contributed more than 34% of revenue share in 2022.
  • Asia-Pacific is estimated to expand the fastest CAGR between 2023 and 2032.
  • By product, the needle-based biopsy guns segment held the largest market share of 36% in 2022.
  • By product, the biopsy needles segment is anticipated to grow at a remarkable CAGR of 8.6% between 2023 and 2032.
  • By end use, the hospitals segment generated over 46% of revenue share in 2022.
  • By end use, the clinics segment is expected to expand at the fastest CAGR over the projected period.

The Biopsy Devices Market is a dynamic and crucial segment within the healthcare industry, playing a pivotal role in the diagnosis and treatment of various medical conditions. Biopsy devices are instrumental in obtaining tissue samples for laboratory analysis, aiding in the identification of diseases such as cancer and other pathological conditions. This market encompasses a diverse range of devices, including needles, forceps, guidance systems, and imaging devices, each designed to enhance precision and efficiency in the biopsy process.

Get a Sample: https://www.precedenceresearch.com/sample/3612

Growth Factors

  1. Technological Advancements: The continuous evolution of biopsy device technologies has significantly contributed to the market’s growth. Advanced imaging techniques, real-time guidance systems, and minimally invasive biopsy procedures have improved accuracy, reduced patient discomfort, and expanded the scope of applications.
  2. Rising Incidence of Cancer: With the global surge in cancer cases, the demand for biopsy devices has witnessed a substantial increase. These devices are essential for early and accurate cancer diagnosis, enabling timely initiation of treatment. As cancer prevalence continues to rise, the biopsy devices market is expected to experience sustained growth.
  3. Increasing Geriatric Population: The demographic shift towards an aging population has led to a higher incidence of age-related diseases, including cancer. Biopsy procedures are frequently required in elderly patients, driving the demand for innovative and less invasive devices to ensure optimal diagnostic outcomes with minimal patient impact.
  4. Growing Awareness and Screening Programs: Public awareness campaigns and organized screening programs for various diseases, particularly cancer, have contributed to an increased demand for biopsy procedures. As more individuals participate in routine screenings, the biopsy devices market is poised for expansion to meet the diagnostic needs of a proactive healthcare consumer base.
  5. Global Healthcare Infrastructure Development: Investments in healthcare infrastructure across the globe have facilitated improved access to advanced medical procedures, including biopsies. Developing regions witnessing an upgrade in their healthcare facilities are likely to be significant contributors to the market’s growth.

Biopsy Devices Market Scope

Report Coverage Details
Growth Rate from 2023 to 2032 CAGR of 7.20%
Market Size in 2023 USD 2.29 Billion
Market Size by 2032 USD 4.29 Billion
Largest Market North America
Base Year 2022
Forecast Period 2023 to 2032
Segments Covered By Application and By End Use
Regions Covered North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa

Read More: X-Ray Detectors Market Size To Rise USD 5.81 Billion By 2032

By Application

In the dynamic landscape of the Biopsy Devices Market, diverse applications drive the demand for these essential medical tools. Cancer diagnosis remains a prominent application, with biopsy devices playing a crucial role in obtaining tissue samples for accurate identification and assessment of malignancies. The precision and efficiency of these devices contribute significantly to early detection and subsequent treatment planning, enhancing the overall prognosis for patients.

By End Use

The Biopsy Devices Market caters to a spectrum of end users, reflecting the widespread utility of these devices across the healthcare industry. Hospitals emerge as major consumers, relying on biopsy tools for diagnostic and therapeutic procedures. Ambulatory surgical centers also play a pivotal role, leveraging these devices to facilitate minimally invasive procedures with reduced patient discomfort. The accessibility and adaptability of biopsy devices make them indispensable for various end users, fostering advancements in medical practices and patient care.

Reasons to Purchase this Report:

  • Comprehensive market segmentation analysis incorporating qualitative and quantitative research, considering the impact of economic and policy factors.
  • In-depth regional and country-level analysis, examining the demand and supply dynamics that influence market growth.
  • Market size in USD million and volume in million units provided for each segment and sub-segment.
  • Detailed competitive landscape, including market share of major players, recent projects, and strategies implemented over the past five years.
  • Comprehensive company profiles encompassing product offerings, key financial information, recent developments, SWOT analysis, and employed strategies by major market players.

Biopsy Devices Market Players

  • Medtronic plc
  • Becton, Dickinson, and Company
  • Hologic, Inc.
  • Boston Scientific Corporation
  • Olympus Corporation
  • C. R. Bard, Inc. (acquired by BD)
  • Cook Medical LLC
  • FUJIFILM Holdings Corporation
  • Mauna Kea Technologies
  • Devicor Medical Products, Inc.
  • Leica Biosystems Nussloch GmbH (Danaher Corporation)
  • INRAD Inc.
  • Argon Medical Devices, Inc. (acquired by Shandong Weigao Group Medical Polymer Company Limited)
  • Scion Medical Technologies LLC
  • MDxHealth SA

Segments Covered in the Report

By Application

  • Needle-based Biopsy Guns
  • Biopsy Guidance Systems
  • Biopsy Forceps
  • Biopsy Needles

By End Use

  • Hospitals
  • Clinics
  • Others

By Geography

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective

1.2. Scope of the Study

1.3. Definition

Chapter 2. Research Methodology (Premium Insights)

2.1. Research Approach

2.2. Data Sources

2.3. Assumptions & Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Market Variables and Scope 

4.1. Introduction

4.2. Market Classification and Scope

4.3. Industry Value Chain Analysis

4.3.1. Raw Material Procurement Analysis

4.3.2. Sales and Distribution Channel Analysis

4.3.3. Downstream Buyer Analysis

Chapter 5. COVID 19 Impact on Biopsy Devices Market 

5.1. COVID-19 Landscape: Biopsy Devices Industry Impact

5.2. COVID 19 – Impact Assessment for the Industry

5.3. COVID 19 Impact: Global Major Government Policy

5.4. Market Trends and Opportunities in the COVID-19 Landscape

Chapter 6. Market Dynamics Analysis and Trends

6.1. Market Dynamics

6.1.1. Market Drivers

6.1.2. Market Restraints

6.1.3. Market Opportunities

6.2. Porter’s Five Forces Analysis

6.2.1. Bargaining power of suppliers

6.2.2. Bargaining power of buyers

6.2.3. Threat of substitute

6.2.4. Threat of new entrants

6.2.5. Degree of competition

Chapter 7. Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis

7.1.2. Key Strategies Adopted by Players

7.1.3. Vendor Landscape

7.1.3.1. List of Suppliers

7.1.3.2. List of Buyers

Chapter 8. Global Biopsy Devices Market, By Application

8.1. Biopsy Devices Market Revenue and Volume, by Application, 2023-2032

8.1.1. Needle-based Biopsy Guns

8.1.1.1. Market Revenue and Volume Forecast (2020-2032)

8.1.2. Biopsy Guidance Systems

8.1.2.1. Market Revenue and Volume Forecast (2020-2032)

8.1.3. Biopsy Forceps

8.1.3.1. Market Revenue and Volume Forecast (2020-2032)

8.1.4. Biopsy Needles

8.1.4.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 9. Global Biopsy Devices Market, By End Use

9.1. Biopsy Devices Market Revenue and Volume, by End Use, 2023-2032

9.1.1. Hospitals

9.1.1.1. Market Revenue and Volume Forecast (2020-2032)

9.1.2. Clinics

9.1.2.1. Market Revenue and Volume Forecast (2020-2032)

9.1.3. Others

9.1.3.1. Market Revenue and Volume Forecast (2020-2032)

Chapter 10. Global Biopsy Devices Market, Regional Estimates and Trend Forecast

10.1. North America

10.1.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.1.2. Market Revenue and Volume Forecast, by End Use (2020-2032)

10.1.3. U.S.

10.1.3.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.1.3.2. Market Revenue and Volume Forecast, by End Use (2020-2032)

10.1.4. Rest of North America

10.1.4.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.1.4.2. Market Revenue and Volume Forecast, by End Use (2020-2032)

10.2. Europe

10.2.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.2.2. Market Revenue and Volume Forecast, by End Use (2020-2032)

10.2.3. UK

10.2.3.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.2.3.2. Market Revenue and Volume Forecast, by End Use (2020-2032)

10.2.4. Germany

10.2.4.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.2.4.2. Market Revenue and Volume Forecast, by End Use (2020-2032)

10.2.5. France

10.2.5.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.2.5.2. Market Revenue and Volume Forecast, by End Use (2020-2032)

10.2.6. Rest of Europe

10.2.6.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.2.6.2. Market Revenue and Volume Forecast, by End Use (2020-2032)

10.3. APAC

10.3.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.3.2. Market Revenue and Volume Forecast, by End Use (2020-2032)

10.3.3. India

10.3.3.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.3.3.2. Market Revenue and Volume Forecast, by End Use (2020-2032)

10.3.4. China

10.3.4.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.3.4.2. Market Revenue and Volume Forecast, by End Use (2020-2032)

10.3.5. Japan

10.3.5.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.3.5.2. Market Revenue and Volume Forecast, by End Use (2020-2032)

10.3.6. Rest of APAC

10.3.6.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.3.6.2. Market Revenue and Volume Forecast, by End Use (2020-2032)

10.4. MEA

10.4.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.4.2. Market Revenue and Volume Forecast, by End Use (2020-2032)

10.4.3. GCC

10.4.3.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.4.3.2. Market Revenue and Volume Forecast, by End Use (2020-2032)

10.4.4. North Africa

10.4.4.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.4.4.2. Market Revenue and Volume Forecast, by End Use (2020-2032)

10.4.5. South Africa

10.4.5.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.4.5.2. Market Revenue and Volume Forecast, by End Use (2020-2032)

10.4.6. Rest of MEA

10.4.6.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.4.6.2. Market Revenue and Volume Forecast, by End Use (2020-2032)

10.5. Latin America

10.5.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.5.2. Market Revenue and Volume Forecast, by End Use (2020-2032)

10.5.3. Brazil

10.5.3.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.5.3.2. Market Revenue and Volume Forecast, by End Use (2020-2032)

10.5.4. Rest of LATAM

10.5.4.1. Market Revenue and Volume Forecast, by Application (2020-2032)

10.5.4.2. Market Revenue and Volume Forecast, by End Use (2020-2032)

Chapter 11. Company Profiles

11.1. Medtronic plc

11.1.1. Company Overview

11.1.2. Product Offerings

11.1.3. Financial Performance

11.1.4. Recent Initiatives

11.2. Becton, Dickinson, and Company

11.2.1. Company Overview

11.2.2. Product Offerings

11.2.3. Financial Performance

11.2.4. Recent Initiatives

11.3. Hologic, Inc.

11.3.1. Company Overview

11.3.2. Product Offerings

11.3.3. Financial Performance

11.3.4. Recent Initiatives

11.4. Boston Scientific Corporation

11.4.1. Company Overview

11.4.2. Product Offerings

11.4.3. Financial Performance

11.4.4. Recent Initiatives

11.5. Olympus Corporation

11.5.1. Company Overview

11.5.2. Product Offerings

11.5.3. Financial Performance

11.5.4. Recent Initiatives

11.6. C. R. Bard, Inc. (acquired by BD)

11.6.1. Company Overview

11.6.2. Product Offerings

11.6.3. Financial Performance

11.6.4. Recent Initiatives

11.7. Cook Medical LLC

11.7.1. Company Overview

11.7.2. Product Offerings

11.7.3. Financial Performance

11.7.4. Recent Initiatives

11.8. FUJIFILM Holdings Corporation

11.8.1. Company Overview

11.8.2. Product Offerings

11.8.3. Financial Performance

11.8.4. Recent Initiatives

11.9. Mauna Kea Technologies

11.9.1. Company Overview

11.9.2. Product Offerings

11.9.3. Financial Performance

11.9.4. Recent Initiatives

11.10. Devicor Medical Products, Inc.

11.10.1. Company Overview

11.10.2. Product Offerings

11.10.3. Financial Performance

11.10.4. Recent Initiatives

Chapter 12. Research Methodology

12.1. Primary Research

12.2. Secondary Research

12.3. Assumptions

Chapter 13. Appendix

13.1. About Us

13.2. Glossary of Terms

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://www.expresswebwire.com/

Blog: https://www.uswebwire.com/

Blog: https://www.dailytechbulletin.com/

Blog: https://www.autoindustrybulletin.com/


Leave a Reply

Your email address will not be published. Required fields are marked *